Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe R Delaney

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Biocell : Official Journal of the Sociedades Latinoamericanas De Microscopia Electronica ... Et. Al|July 16, 2021
Aneuploidy: An Opportunity Within Single-Cell RNA Sequencing AnalysisJoe R Delaney
Genes|June 26, 2025
Half the Chromosome It Used to Be: Identifying Cancer Treatments Targeting Aneuploid LossesAndrew O Disharoon, Joe R Delaney
STAR Protocols|March 31, 2023
Protocol for mapping double-stranded DNA break sites across the genome with translocation capture sequencingJoe R Delaney, Albert R La Spada
Cell Cycle (Georgetown, Tex.)|October 30, 2020
Single-cell analysis of copy-number alterations in serous ovarian cancer reveals substantial heterogeneity in both low- and high-grade tumorsManonmani Kumar, Robert R Bowers, Joe R Delaney
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2014
Replicative life span analysis in budding yeastGeorge L Sutphin, Joe R Delaney, Matt Kaeberlein
Trends in Cancer|April 30, 2020
Treating the Disease, Not the Symptom: Beyond NSAIDsRobert R Bowers, Joe R Delaney, Demetri D Spyropoulos
Frontiers in Toxicology|July 18, 2022
Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological ToxicityKristi L Helke, Radhika R Gudi, Chenthamarakshan Vasu, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Quantitative evidence for early life fitness defects from 32 longevity-associated alleles in yeastJoe R Delaney, Christopher J Murakami, Brady Olsen, et al.
Biology Open|August 11, 2025
PIWIL2 downregulation in colon cancer promotes transposon activity and pro-tumorigenic phenotypesAlyssa Risner, Joyce Nair-Menon, Abhinav Cheedipudi, et al.
Drug Design, Development and Therapy|June 23, 2016
Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settingsMitzie-Ann Davis, Joe R Delaney, Chandni B Patel, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Biocell : Official Journal of the Sociedades Latinoamericanas De Microscopia Electronica ... Et. Al|July 16, 2021
Aneuploidy: An Opportunity Within Single-Cell RNA Sequencing AnalysisJoe R Delaney
Genes|June 26, 2025
Half the Chromosome It Used to Be: Identifying Cancer Treatments Targeting Aneuploid LossesAndrew O Disharoon, Joe R Delaney
STAR Protocols|March 31, 2023
Protocol for mapping double-stranded DNA break sites across the genome with translocation capture sequencingJoe R Delaney, Albert R La Spada
Cell Cycle (Georgetown, Tex.)|October 30, 2020
Single-cell analysis of copy-number alterations in serous ovarian cancer reveals substantial heterogeneity in both low- and high-grade tumorsManonmani Kumar, Robert R Bowers, Joe R Delaney
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2014
Replicative life span analysis in budding yeastGeorge L Sutphin, Joe R Delaney, Matt Kaeberlein
Trends in Cancer|April 30, 2020
Treating the Disease, Not the Symptom: Beyond NSAIDsRobert R Bowers, Joe R Delaney, Demetri D Spyropoulos
Frontiers in Toxicology|July 18, 2022
Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological ToxicityKristi L Helke, Radhika R Gudi, Chenthamarakshan Vasu, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Quantitative evidence for early life fitness defects from 32 longevity-associated alleles in yeastJoe R Delaney, Christopher J Murakami, Brady Olsen, et al.
Biology Open|August 11, 2025
PIWIL2 downregulation in colon cancer promotes transposon activity and pro-tumorigenic phenotypesAlyssa Risner, Joyce Nair-Menon, Abhinav Cheedipudi, et al.
Drug Design, Development and Therapy|June 23, 2016
Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settingsMitzie-Ann Davis, Joe R Delaney, Chandni B Patel, et al.
Pageof 5